SHERIDAN, WYOMING – November 09, 2024– In a move set to transform blood processing in the United States, Terumo Blood and Cell Technologies (Terumo BCT) has launched the Reveos™ Automated Blood Processing System. This innovative technology, already used in over 50 countries for more than a decade, promises to significantly enhance efficiency and address critical platelet shortages.
"Reveos is a revolutionary technology that automates whole blood processing. By streamlining the process, it significantly improves efficiency and consistency compared to traditional manual methods used by U.S. blood centers," says Chetan Makam, General Manager, Global Blood Solutions, Terumo BCT. "It's a new way to be more efficient for blood centers, for processing whole blood into its components including platelets. Reveos will help blood centers do more with the blood donors already walking through the doors."
Until now, processing whole blood donations in the U.S. involved a laborious manual process of over 20 steps. Reveos simplifies this by automating the separation of whole blood into its key components – platelets, plasma, and red blood cells – in a single centrifugation cycle. This streamlined approach not only saves time and resources but also maximizes the yield from each donation, a crucial factor in combating platelet shortages.
Blood Centers of America (BCA), a network of over 50 independent blood centers, is leading the way in adopting this new technology. "Reveos is a great fit because we're interested in using technology to make blood donation centers more efficient," says Bill Block, Chief Executive Officer and President, BCA. "It helps us keep up with the increasing need for blood while also making things more operationally efficient, and that in turn, should help ease some of the labor force pressures our centers are experiencing."
Reveos: A Game Changer for Blood Centers
The Reveos system offers a multitude of benefits for blood centers:
Increased Efficiency: By automating the process, Reveos significantly reduces the hands-on time required for blood processing, freeing up staff for other critical tasks. In fact, it can reduce manual steps by up to 65%.
Cost Savings: Automation leads to reduced operational costs, allowing blood centers to allocate resources more effectively.
Improved Productivity:** With fewer manual steps and streamlined workflows, blood centers can process more donations with the same amount of staff.
Enhanced Yield: Reveos maximizes the number of blood products derived from each donation, helping to address critical shortages, particularly for platelets.
Addressing the Platelet Shortage
Platelets play a vital role in blood clotting and are essential for treating patients with various conditions, including trauma, cancer, and chronic diseases. The launch of Reveos comes at a crucial time when blood centers are grappling with platelet shortages and staffing challenges. By optimizing blood processing and increasing platelet yields, Reveos offers a much-needed solution to ensure a reliable supply of these life-saving components.
How Reveos Works
The Reveos system is remarkably user-friendly. Up to four units of whole blood are loaded into the device, and the automated process begins. The centrifuge spins, separating the blood into its components, which are then expressed into individual bags and sealed. All data is recorded on Terumo BCT's Lumia™ Software Platform, which connects with Reveos to provide comprehensive data management and analysis capabilities.
A Global Solution with Local Impact
With over 785 Reveos devices already in use across 57 countries, the system has a proven track record of success. Its introduction to the U.S. marks a significant step forward in blood processing technology, promising to improve efficiency, address critical shortages, and ultimately benefit patients in need.